(Q45731096)

15 December 2017

A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

Reynolds WF

1

1 reference

15 December 2017

Patel K

2

1 reference

15 December 2017

Pianko S

3

1 reference

15 December 2017

Blatt LM

4

1 reference

15 December 2017

Nicholas JJ

5

1 reference

15 December 2017

McHutchison JG

6

1 reference

15 December 2017

1 September 2002

1 reference

15 December 2017

1 reference

15 December 2017

3

1 reference

15 December 2017

345-349

1 reference

15 December 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gene.6363880

15 December 2017

0 references

cites work

New kit on the block: Evaluation of second-generation assays for detection of antibody to the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Discovery of non-A, non-B hepatitis and identification of its etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Acetaldehyde-protein adducts, but not lactate and pyruvate, stimulate gene transcription of collagen and fibronectin in hepatic fat-storing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Hepatic stellate cells: a target for the treatment of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Pathogenesis of liver fibrosis: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Vitamin A-containing lipocytes and formation of type III collagen in liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Myeloperoxidase--463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Increased atherosclerosis in myeloperoxidase-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

In vitro peroxidase oxidation induces stable dimers of beta-amyloid (1-42) through dityrosine bridge formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Nitric oxide is a physiological substrate for mammalian peroxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

Possible Risk Reduction in Esophageal Cancer Associated with MPO-463 A allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

7 January 2021

A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

7 January 2021

Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

7 January 2021

Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GENE.6363880

7 January 2021

Identifiers

DOI

10.1038/SJ.GENE.6363880

1 reference

Dimensions Publication ID

15 December 2017

0 references

1 reference